Early endpoints for acute bacterial skin and skin structure infections.
Institute for Therapeutic Innovation, University of Florida School of Medicine, Albany, New York, USA. George.Drusano@medicine.ufl.edu
George L
GL
Drusano
D001398:Aztreonam / Q000627:therapeutic use*; D015415:Biomarkers / Q000032:analysis*; D002511:Cephalosporins / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D017192:Skin Diseases, Bacterial / Q000188:drug therapy*; D014640:Vancomycin / Q000627:therapeutic use*; D000097583:Ceftaroline
D001398:Aztreonam; D015415:Biomarkers; D002511:Cephalosporins; D014640:Vancomycin; D000097583:Ceftaroline